To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
UK biotech start-up raises £3m on AIM(2)
UK biotech spin-out EpiStem has raised £3m from its flotation on AIM. 33 venture capital sources, and UK business angel network Beer & Partners, have backed the initial public offering.
